1. Home
  2. WKHS vs OSRH Comparison

WKHS vs OSRH Comparison

Compare WKHS & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Workhorse Group Inc.

WKHS

Workhorse Group Inc.

HOLD

Current Price

$3.50

Market Cap

17.4M

ML Signal

HOLD

Logo OSR Holdings Inc.

OSRH

OSR Holdings Inc.

HOLD

Current Price

$0.41

Market Cap

18.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKHS
OSRH
Founded
2007
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
17.4M
18.4M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
WKHS
OSRH
Price
$3.50
$0.41
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$21.00
N/A
AVG Volume (30 Days)
69.6K
348.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$763,173.00
N/A
Revenue This Year
$81.01
N/A
Revenue Next Year
$34.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.19
$0.38
52 Week High
$11.80
$4.33

Technical Indicators

Market Signals
Indicator
WKHS
OSRH
Relative Strength Index (RSI) 36.86 35.85
Support Level $0.90 $0.39
Resistance Level $6.00 $0.47
Average True Range (ATR) 0.22 0.04
MACD 0.01 0.00
Stochastic Oscillator 37.66 20.82

Price Performance

Historical Comparison
WKHS
OSRH

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

About OSRH OSR Holdings Inc.

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

Share on Social Networks: